Nektar Therapeutics NKTR Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Nektar Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's asset turnover?
- Nektar Therapeutics (NKTR) reported asset turnover of 0.1× in Q1 2026.
- How has Nektar Therapeutics's asset turnover changed year-over-year?
- Nektar Therapeutics's asset turnover decreased by 59.2% year-over-year, from 0.3× to 0.1×.
- What is the long-term trend for Nektar Therapeutics's asset turnover?
- Over 5 years (2020 to 2025), Nektar Therapeutics's asset turnover has grown at a 16.8% compound annual growth rate (CAGR), from 0.1× to 0.2×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.